Skip to content
  • About
  • Contact
  • Contribute
  • What Physicians Say
  • My Book
  • Careers
  • Podcast
  • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Aging and dementia: what physicians say, in their own words
  • Artificial intelligence: what physicians say, in their own words
  • Be heard on social media’s leading physician voice
  • Cancer: what physicians say, in their own words
  • Children’s health: what pediatricians say, in their own words
  • Contact Kevin
  • COVID-19: what physicians wrote as it happened
  • Custom enhanced author page pricing
  • Diabetes and obesity: what physicians say, in their own words
  • Direct primary care: what physicians say, in their own words
  • DMCA Policy
  • End of life: what physicians say, in their own words
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • GLP-1 drugs: what physicians say about Ozempic and its successors, in their own words
  • Heart disease: what physicians say, in their own words
  • Immigration and medicine: what physicians say about immigrant doctors and immigrant patients, in their own words
  • KevinMD influencer opportunities
  • Medical errors: what physicians say, in their own words
  • Medical ethics: what physicians say, in their own words
  • Medical malpractice: what physicians say, in their own words
  • Medical school: what students and physicians say, in their own words
  • Mental health: what psychiatrists and physicians say, in their own words
  • Nursing: what nurses and physicians say, in their own words
  • Opinion and commentary by KevinMD
  • Opioids: what physicians and pain patients say, in their own words
  • Physician burnout speakers to keynote your conference
  • Physician burnout: what physicians say, in their own words
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician personal finance: what physicians say about their own money, in their own words
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Physician suicide: what physicians say, in their own words
  • Physicians and administrators: what physicians say about who runs medicine, in their own words
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Primary care: what physicians say, in their own words
  • Prior authorization: what physicians say, in their own words
  • Privacy Policy
  • Private equity and corporate medicine: what physicians say, in their own words
  • Race and medicine: what physicians say, in their own words
  • Recommended services by KevinMD
  • Residency: what residents and attendings say, in their own words
  • Scope of practice: what physicians, nurse practitioners, and PAs say, in their own words
  • Subscribe to the KevinMD enhanced author page
  • Subscribe to the newsletter
  • Surgeons and surgery: what surgeons say, in their own words
  • Take-home messages: what physicians say when asked to leave one
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • The electronic health record: what physicians say, in their own words
  • Vaccines: what physicians say, in their own words
  • Violence against health care workers: what physicians and nurses say, in their own words
  • What physicians say: the KevinMD records
  • Women in medicine: what women physicians say, in their own words
  • Women’s health: what physicians say, in their own words

How business will affect pharmaceutical reps

Steve Woodruff
Medications
May 11, 2011
Share
Tweet
Share

There’s been a lot of talk in the past year about how we need to re-think the role and profile of the pharmaceutical/biotech sales rep.

This dialogue needs to happen, given the trends that are rapidly shrinking the size of sales forces. Of course, when you poll the doctors, they are going to focus on the need for greater depth of clinical knowledge. That’s certainly important. And, if you talk to the rest of the staff, then knowledge of health plans and administrative/business issues rise to the surface. As you’d expect.

But now, let’s take a look at it from the shoes of the pharmaceutical company – the executives and managers responsible for outreach to the medical community. What does the new rep need to look like with their perspective in mind?

The old model had much to do with reach and frequency – getting the message out. Looking ahead, I think it’s going to require a mentality much more focused on opportunity and strategy – that is, approaching one’s job as a business, and intelligently using available information to maximize proper patient use of the most appropriate therapy.

Often this includes training in something like business acumen, but perhaps a more helpful description of the overall mindset would be something along the lines of business opportunism – savviness/insight joined to creative initiative and enterprising strategy (including pulling in other resources) to accomplish the desired business end. And while one means may be messaging with reach and frequency in mind, that is certainly NOT the end!

A business opportunist would look at the accounts in a territory with a thoughtful finger on the pulse of prescribing volume AND current prescribing habits AND treatment practices AND health plan coverage variations AND patient flow AND other important variables, and be empowered to ask this question: “Where is the greatest potential impact for the most (appropriate) patients?” This is a very different mindset than, “How can I make my call numbers this week?”

Better clinical training instead of meal-and-message-delivery services? Absolutely. Healthcare and office process knowledge? Certainly. But perhaps it’s time to re-think the whole sales rep model, and start deploying business opportunists. I’m thinking advanced training for reps who have been in the field for a year or two should be geared more toward strategic business skills.

Steve Woodruff is Founder and President of Impactiviti.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

How podcasts can help patients with health literacy

May 11, 2011 Kevin 2
…
Next

My interviews on patient engagement and social media

May 11, 2011 Kevin 1
…

Tagged as: Medications and Prescribing

< Previous Post
How podcasts can help patients with health literacy
Next Post >
My interviews on patient engagement and social media

 

ADVERTISEMENT

More by Steve Woodruff

  • a desk with keyboard and ipad with the kevinmd logo

    Educated online by people with diabetes

    Steve Woodruff
  • a desk with keyboard and ipad with the kevinmd logo

    Why the female Viagra quest is fundamentally misguided

    Steve Woodruff
  • a desk with keyboard and ipad with the kevinmd logo

    How drug information fine print fails to communicate

    Steve Woodruff

Related Posts

  • How fentanyl misinformation turns suspicion into fact

    Lynn R. Webster, MD
  • The conflict of interest that discloses as nothing

    Martha Rosenberg
  • You could soon be taking (or prescribing) a drug developed by AI

    Jennifer Bath, PhD
  • Are you storing your medications wrong?

    Dr. Farees Ahmad Khan & Dr. Sarah Alnaher
  • Is your patient’s new symptom a prescribing cascade?

    Narinder Singh Parhar, MD
  • Too many older adults are taking risky sedative medications

    Wendy Levinson, MD and Christine Soong, MD

More in Medications

  • The conflict of interest that discloses as nothing

    Martha Rosenberg
  • Why cannabis use disorder and withdrawal go unnoticed

    Ginger Constantine, MD
  • How fentanyl misinformation turns suspicion into fact

    Lynn R. Webster, MD
  • The nociplastic pain question new pain therapies avoid

    Amir Friedman, MD
  • mRNA hype moves faster than the evidence behind it

    Harry Oken, MD
  • Side effects of osteoporosis drugs the trials never proved

    Michael Duben, MD
  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • Hospital IT approval has no path for clinician-built tools

      Sanjay Khicha, MD and Gautam Nayak, MD | Health Technology
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology
    • How AI phone systems in health care create barriers

      Thuy D. Bui, MD | Health Technology
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 10 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • Hospital IT approval has no path for clinician-built tools

      Sanjay Khicha, MD and Gautam Nayak, MD | Health Technology
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology
    • How AI phone systems in health care create barriers

      Thuy D. Bui, MD | Health Technology
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use Agreement
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How business will affect pharmaceutical reps
10 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...